 |
| Canada Clinical Nutrition Market |
The Canada clinical nutrition market space is experiencing steady growth owing to rising incidences of chronic diseases such as cancer, diabetes, cardiovascular diseases and other lifestyle related ailments. Clinical nutrition products play an important role in disease management and rehabilitation. Rising health awareness and demand for specialized nutrition are key factors driving significant interest in products such as parenteral nutrition, enteral nutrition and dietary supplements.
The Canada clinical nutrition market is estimated to be
valued at US$ 751.73 Bn in 2024 and is expected to exhibit a CAGR of 54.% over the
forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Canada clinical nutrition are Audi AG, Ballard
Power Systems Inc., BMW Group, Daimler AG, General Motors Company, Honda Motor
Co., Ltd., and Hyundai Motor Group. These players are focusing on improving
their product portfolio and expanding manufacturing facilities to leverage the
market opportunity.
The rising cases of chronic diseases provide numerous growth opportunities for
clinical nutrition manufacturers in Canada. The development of disease specific
nutritional products will be a major focus area. Factors such as an aging
population, rising obesity and focus on preventive healthcare are creating
conducive environment.
Clinical nutrition companies are actively looking to expand globally to
capitalize on the rapid growth anticipated across different world regions.
Strategic acquisitions are expected to help companies strengthen distribution
networks and product lines. North America and Asia Pacific are identified as
key target markets going forward.
Market drivers
One of the key drivers for the clinical nutrition market in Canada is the
rising prevalence of chronic and lifestyle diseases. According to estimates,
nearly 6 in 10 Canadians suffer from chronic ailments. This widespread
incidence of diseases like cancer and diabetes is generating significant demand
for nutritional interventions and diet management. The proven role of
specialized nutrition in disease treatment and recovery continues to attract
higher spending on clinical nutrition products.
Market restraints
While demand is on an upswing, low awareness regarding the tangible benefits of
clinical nutrition poses a key challenge. There needs to more focus on
imparting nutrition education and demonstrating impact to drive further
acceptance and sales growth. Other restraints include difficulties associated
with establishing efficacy of some nutritional interventions. This affects
insurance coverage and reimbursements to some degree.
Segment Analysis
The Canada
Clinical Nutrition Market Growth is segmented based on route of administration
into enteral nutrition and parenteral nutrition. The enteral nutrition segment
is expected dominate the market during the forecast period. Enteral nutrition
is the most common and preferred route of administration as it is relatively
less expensive and has lower risk of infections compared to parenteral
nutrition. The enteral nutrition segment accounted for around 70% of the total
clinical nutrition market share in 2024.
Global Analysis
The Canada clinical nutrition market is expected to witness the fastest growth
in Western Canada during 2024-2030. Provinces like British Columbia and Alberta
are expected to showcase growth rates above the national average. This can be
attributed to rising geriatric population, increasing prevalence of chronic
diseases like cancer and growing awareness about clinical nutrition therapy.
Western Canada accounted for over 35% of the total clinical nutrition sales in
the country in 2024. Asia Pacific region is anticipated to be the fastest
growing market for clinical nutrition globally during the forecast period, led
by countries like China, India, Japan and Australia.
0 Comments